138 related articles for article (PubMed ID: 10232419)
1. High pleural fluid hyaluronan concentrations in rheumatoid arthritis.
Söderblom T; Pettersson T; Nyberg P; Teppo AM; Linko L; Riska H
Eur Respir J; 1999 Mar; 13(3):519-22. PubMed ID: 10232419
[TBL] [Abstract][Full Text] [Related]
2. Pleural fluid interferon-gamma and tumour necrosis factor-alpha in tuberculous and rheumatoid pleurisy.
Söderblom T; Nyberg P; Teppo AM; Klockars M; Riska H; Pettersson T
Eur Respir J; 1996 Aug; 9(8):1652-5. PubMed ID: 8866589
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronan in pleural effusions and in serum.
Hillerdal G; Lindqvist U; Engström-Laurent A
Cancer; 1991 May; 67(9):2410-4. PubMed ID: 2013045
[TBL] [Abstract][Full Text] [Related]
4. Vascular endothelial growth factor and proinflammatory cytokines in pleural effusions.
Momi H; Matsuyama W; Inoue K; Kawabata M; Arimura K; Fukunaga H; Osame M
Respir Med; 2002 Oct; 96(10):817-22. PubMed ID: 12412982
[TBL] [Abstract][Full Text] [Related]
5. Utility of hyaluronic acid in pleural fluid for differential diagnosis of pleural effusions: likelihood ratios for malignant mesothelioma.
Atagi S; Ogawara M; Kawahara M; Sakatani M; Furuse K; Ueda E; Yamamoto S
Jpn J Clin Oncol; 1997 Oct; 27(5):293-7. PubMed ID: 9390204
[TBL] [Abstract][Full Text] [Related]
6. Hyaluronan in serum as an indicator of progressive disease in hyaluronan-producing malignant mesothelioma.
Thylén A; Wallin J; Martensson G
Cancer; 1999 Nov; 86(10):2000-5. PubMed ID: 10570424
[TBL] [Abstract][Full Text] [Related]
7. Concentration of hyaluronic acid in pleural fluid as a diagnostic aid for malignant mesothelioma.
Pettersson T; Fröseth B; Riska H; Klockars M
Chest; 1988 Nov; 94(5):1037-9. PubMed ID: 3180855
[TBL] [Abstract][Full Text] [Related]
8. Proinflammatory cytokines, transforming growth factor-beta1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates.
Chung CL; Chen CH; Sheu JR; Chen YC; Chang SC
Chest; 2005 Aug; 128(2):690-7. PubMed ID: 16100155
[TBL] [Abstract][Full Text] [Related]
9. [The significance of detecting tumor necrosis factor-alpha and its receptors in serum and pleural effusion in differentiating tuberculosis and malignant pleural effusions].
Zhou J; Zhao Q; Yao H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Mar; 23(3):158-60. PubMed ID: 11778489
[TBL] [Abstract][Full Text] [Related]
10. Pleural fluid beta-2-microglobulin and angiotensin-converting enzyme concentrations in rheumatoid arthritis and tuberculosis.
Söderblom T; Nyberg P; Pettersson T; Klockars M; Riska H
Respiration; 1996; 63(5):272-6. PubMed ID: 8884998
[TBL] [Abstract][Full Text] [Related]
11. Clinical utility of pleural fluid NT-pro brain natriuretic peptide (NT-proBNP) in patients with pleural effusions.
Han CH; Choi JE; Chung JH
Intern Med; 2008; 47(19):1669-74. PubMed ID: 18827414
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin as a diagnostic marker in differentiating parapneumonic effusion from tuberculous pleurisy or malignant effusion.
Lee SH; Lee EJ; Min KH; Hur GY; Lee SY; Kim JH; Shin C; Shim JJ; In KH; Kang KH; Lee SY
Clin Biochem; 2013 Oct; 46(15):1484-8. PubMed ID: 23570862
[TBL] [Abstract][Full Text] [Related]
13. Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions.
Hua CC; Chang LC; Chen YC; Chang SC
Chest; 1999 Nov; 116(5):1292-6. PubMed ID: 10559090
[TBL] [Abstract][Full Text] [Related]
14. Tumour necrosis factor alpha in the diagnostic assessment of pleural effusion.
Odeh M; Sabo E; Srugo I; Oliven A
QJM; 2000 Dec; 93(12):819-24. PubMed ID: 11110589
[TBL] [Abstract][Full Text] [Related]
15. Predicting Malignant and Paramalignant Pleural Effusions by Combining Clinical, Radiological and Pleural Fluid Analytical Parameters.
Herrera Lara S; Fernández-Fabrellas E; Juan Samper G; Marco Buades J; Andreu Lapiedra R; Pinilla Moreno A; Morales Suárez-Varela M
Lung; 2017 Oct; 195(5):653-660. PubMed ID: 28656381
[TBL] [Abstract][Full Text] [Related]
16. Interleukin 6 and its relationship to clinical parameters in patients with malignant pleural mesothelioma.
Nakano T; Chahinian AP; Shinjo M; Tonomura A; Miyake M; Togawa N; Ninomiya K; Higashino K
Br J Cancer; 1998 Mar; 77(6):907-12. PubMed ID: 9528833
[TBL] [Abstract][Full Text] [Related]
17. The sensitivity of hyaluronan analysis of pleural fluid from patients with malignant mesothelioma and a comparison of different methods.
Martensson G; Thylen A; Lindquist U; Hjerpe A
Cancer; 1994 Mar; 73(5):1406-10. PubMed ID: 8111707
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic value of interleukin-1alpha, interleukin-6, and tumor necrosis factor in pleural effusions.
Xirouchaki N; Tzanakis N; Bouros D; Kyriakou D; Karkavitsas N; Alexandrakis M; Siafakas NM
Chest; 2002 Mar; 121(3):815-20. PubMed ID: 11888965
[TBL] [Abstract][Full Text] [Related]
19. Pleural interleukin-1 beta in differentiating transudates and exudates: comparative analysis with other biochemical parameters.
Alexandrakis MG; Kyriakou D; Alexandraki R; Pappa KA; Antonakis N; Bouros D
Respiration; 2002; 69(3):201-6. PubMed ID: 12097761
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in the diagnosis of pleural diseases: a 2018 update.
Porcel JM
Ther Adv Respir Dis; 2018; 12():1753466618808660. PubMed ID: 30354850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
